Grade 4 myelosuppression following the first chemotherapy in newly diagnosed lymphomas: results of a prospective study with a long-term follow-up
Medical Oncology · 20.11.2026 · 43 (12)
DOI: 10.1007/s12032-026-03574-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Oncology, online erschienen am 20.11.2026. Verfasst von Weili Xue und 10 weiteren Autor:innen. Die Arbeit nennt 29 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Xue, W., Liu, Z., Song, Y., Yu, H., Chang, Y., Nan, F., Li, Y., Zhang, X., Zhang, L., Zhang, T., & Zhang, M. (2026). Grade 4 myelosuppression following the first chemotherapy in newly diagnosed lymphomas: results of a prospective study with a long-term follow-up. Medical Oncology, 43(12). https://doi.org/10.1007/s12032-026-03574-2
Vancouver
Xue W, Liu Z, Song Y, Yu H, Chang Y, Nan F, et al. Grade 4 myelosuppression following the first chemotherapy in newly diagnosed lymphomas: results of a prospective study with a long-term follow-up. Medical Oncology. 2026;43(12). doi:10.1007/s12032-026-03574-2
BibTeX
@article{Xue2026,
author = {Xue, Weili and Liu, Zhuling and Song, Yue and Yu, Hui and Chang, Yu and Nan, Feifei and Li, Yaqing and Zhang, Xudong and Zhang, Lei and Zhang, Tiantian and Zhang, Mingzhi},
title = {Grade 4 myelosuppression following the first chemotherapy in newly diagnosed lymphomas: results of a prospective study with a long-term follow-up},
journal = {Medical Oncology},
year = {2026},
volume = {43},
number = {12},
doi = {10.1007/s12032-026-03574-2}
}
EUVIMED